Science

Nutella not planet’s friend, says French minister

Nutella not planet’s friend, says French minister

French Environment Minister Ségolène Royal has sparked a debate over Nutella after announcing in a recent interview with French TV…
IVF doctors aghast at 65-year-old mum of quadruplets

IVF doctors aghast at 65-year-old mum of quadruplets

Experts at a top fertility conference are dismayed at the case of a German woman who after having 13 children…
Fifteen years after smokers quit, heart failure risk may fall to normal

Fifteen years after smokers quit, heart failure risk may fall to normal

For most former smokers who quit at least 15 years ago, the risks of heart failure and death are the…
What is trans fat? A look at different kinds of fats

What is trans fat? A look at different kinds of fats

The FDA is phasing out artificial trans fats from the food supply, but people should limit their intake of saturated…
Daily chocolate consumption may be good for the heart: study

Daily chocolate consumption may be good for the heart: study

New research has added to tentative evidence that eating chocolate in modest quantities may be good for the heart, scientists…
Minister: Cairo eastern wall renovated for $8.5 million

Minister: Cairo eastern wall renovated for $8.5 million

Antiquities Minister Mohamed al-Damaty has said that the total cost of the renovation of Cairo's eastern wall, which began in…
Want to eat less?

Want to eat less?

Your dinner partner can have a big influence on your eating habits, especially when it comes to how much you…
Minor operation greatly boosts risk of very premature births

Minor operation greatly boosts risk of very premature births

One of the commonest surgical procedures in gynaecology greatly increases the risk that a woman will give birth prematurely in…
Egyptian shroud set for rare auction in Paris

Egyptian shroud set for rare auction in Paris

A rare ancient Egyptian burial cloth more than 3,000 years old is to go under the hammer on Thursday in…
Avalanche eye therapy meets safety goal; vision improvement modest

Avalanche eye therapy meets safety goal; vision improvement modest

Avalanche Biotechnologies Inc's experimental gene therapy for a leading cause of blindness met its primary safety goal in a small…
Back to top button